Similar articles

• Oral cyclosporine pharmacokinetics in pediatric renal and liver transplant recipients.

  Cooney GF, Dunn SP, Kaiser B, Kulinsky AV, Mochon M, Heifets M. Cooney GF, et al. Transplant Proc. 1994 Oct;26(5):2779-80. Transplant Proc. 1994. PMID: 7940876 Clinical Trial. No abstract available.
• Pharmacokinetics of oral cyclosporine in children awaiting renal transplantation.

  Gusmano R, Verrina E, Piaggio G, Corbetta G, Basile GC, Perfumo F. Gusmano R, et al. Transplant Proc. 1994 Oct;26(5):2781-3. Transplant Proc. 1994. PMID: 7940877 Clinical Trial. No abstract available.
• Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients.

  Sketris IS, Lawen JG, Beauregard-Zollinger L, Belitsky P, Landsberg D, Givner ML, Keown P. Sketris IS, et al. Transplant Proc. 1994 Oct;26(5):2961-3. Transplant Proc. 1994. PMID: 7940935 Clinical Trial. No abstract available.
• Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

  Holt DW, Mueller EA, Kovarik JM, van Bree JB, Richard F, Kutz K. Holt DW, et al. Transplant Proc. 1995 Feb;27(1):1434-7. Transplant Proc. 1995. PMID: 7878935 Review. No abstract available.
• The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

  Holt DW, Mueller EA, Kovarik JM, van Bree JB, Kutz K. Holt DW, et al. Transplant Proc. 1994 Oct;26(5):2935-9. Transplant Proc. 1994. PMID: 7940927 Review. No abstract available.